Monthly Archives: August 2012

  • 22 August 2012

    HARP-2

    The Harp-2 trial is designed to test the hypothesis that patients with a condition called acute lung injury (ALI) will benefit from treatment with a specific daily dose of a drug called simvastatin for up to 28 days.

  • 10 August 2012

    Trial begins of rapid use of clotting drug

    Researchers at the SRMRC have begun a trial to test the practicality of the rapid administering of a drug called Cryoprecipitate, to help stop bleeding in patients who have suffered a serious injury. Cryoprecipitate is a drug…

  • 02 August 2012

    SRMRC nurses – fingers on the pulse

    “We do see a lot of very sick people and it can be quite heartbreaking, but we know that the research we’re doing will help a lot of people in the long run,” says Sister Aisling Clarkson of the work she and her colleagues do to recruit patients to SRMRC studies.